Global Smart Implants Market Report and Forecast 2023-2031

Global Smart Implants Market Report and Forecast 2023-2031

Global Smart Implants Market Outlook

The global smart implants market size was valued at USD 46 million in 2022 and is projected to grow at a CAGR of 29.28% during the forecast period of 2023-2031 to reach a value of USD 477 million by 2031. The market growth can be attributed to the increasing incidence of chronic diseases, advancements in implant technology, and the growing demand for minimally invasive surgeries.

Global Smart Implants Market: Introduction

Smart implants refer to devices that incorporate advanced technologies, such as sensors, wireless communication, and artificial intelligence, to provide real-time monitoring and feedback. These devices are designed to improve patient outcomes, reduce the risk of complications, and enhance the effectiveness of medical treatments. The increasing incidence of chronic diseases such as cardiovascular and neurological diseases, coupled with the growing demand for minimally invasive surgeries, is driving the demand for smart implants.

Technological advancements, such as the development of biocompatible materials, improved sensors, and wireless communication, are also expected to drive market growth. The need for personalized healthcare solutions and the emergence of innovative implant technologies are other significant drivers. Key trends in the market include the increasing adoption of minimally invasive procedures, rising demand for personalized healthcare, the growing prevalence of chronic diseases, and the emergence of innovative implant technologies. As the need for more efficient and effective healthcare solutions continues to rise, the smart implants market is expected to witness significant growth in the coming years.

Applications and Uses

The smart implants market has several applications, including orthopaedic, cardiovascular, neurological, and dental implants. These devices are used to monitor patient conditions, deliver drugs, provide real-time feedback, and improve treatment outcomes. Smart implants offer several advantages, such as reduced recovery time, improved patient comfort, and enhanced precision during surgeries. They also enable remote monitoring and telemedicine, which can help reduce healthcare costs and improve patient access to care. As the demand for more efficient and effective healthcare solutions continues to rise, the smart implants market is expected to witness significant growth in the coming years, driven by the increasing prevalence of chronic diseases and the need for personalized healthcare solutions.

Smart Implants Market Segmentations

The market can be segmented based on product type, material, application, distribution channel, and region:

Market Breakup by Product

  • Orthopaedic Implants
  • Hip Reconstruction
  • Knee Reconstruction
  • Shoulder Reconstruction
  • Spinal Implants
  • Trauma Implants
  • Dental Implants
  • Angiography Implants
  • Vascular Closure Devices
  • Angiography Accessories
  • Others
Market Breakup by Material
  • Bone Cement
  • Metal
  • Cobalt
  • Alloy
  • Titanium
  • Others
Market Breakup by Distribution Channel
  • Hospitals
  • Ambulatory Surgical Centres
  • Clinics
  • Research Laboratories
Telemedicine Market Breakup by Region
  • North America
  • United States of America
  • Canada
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others
Smart Implants Market Scenario

The global smart implants market has experienced significant growth over the past few years, driven by factors such as increasing prevalence of chronic diseases, advancements in implant technology, and growing demand for minimally invasive surgeries. North America dominates the market due to the presence of major market players, high healthcare spending, and increasing demand for personalized healthcare solutions. Europe and Asia Pacific regions are also expected to witness significant growth in the smart implants market, driven by increasing healthcare expenditure and growing patient awareness about advanced medical treatments. The COVID-19 pandemic has also contributed to the growth of the smart implants market, as healthcare providers have been forced to adopt remote monitoring and telemedicine to reduce the risk of infection and ensure patient safety. The pandemic has accelerated the adoption of digital health technologies and created new opportunities for innovation and growth in the smart implants market.

The market for smart implants is expected to continue to grow in the coming years, as the demand for advanced medical devices and personalized healthcare solutions increases. Technological advancements, such as the development of biocompatible materials, improved sensors, and wireless communication, are also expected to drive market growth. The smart implants market presents vast opportunities for innovation and expansion, and it is expected to play a critical role in shaping the future of healthcare.

Key Players in the Global Smart Implants Market

The report provides a detailed analysis of the key players involved in the smart implants market, including their business overview, product portfolio, recent developments, and financial analysis. Some of the major players operating in the market include:
  • Johnson & Johnson Services, Inc.
  • Medronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Nevro Corp.
  • Zimmer Biomet
  • Cochlear Ltd.
  • Biotronik
  • Seneonics, Inc.
  • Intelligent Implants
  • Freudenberg Group
  • AstraZeneca
  • Integra LifeSciences

*Please Note:* The report will be completed in 7 business days after order confirmation


1 Preface
1.1 Key Assumptions
2 Research Methodology
3 Executive Summary
4 Global Smart Implants Market
4.1 Global Smart Implants Market Overview
4.2 Global Smart Implants Market Analysis
4.2.1 Market Overview
4.2.1.1 Global Smart Implants Market Historical Value (2016-2022)
4.2.1.2 Global Smart Implants Market Forecast Value (2023-2031)
4.3 Global Smart Implants Market by Product
4.3.1 Market Overview
4.3.2 Orthopaedic Implants
4.3.2.1 Hip Reconstruction
4.3.2.2 Knee Reconstruction
4.3.2.3 Shoulder Implants
4.3.2.4 Spinal Implants
4.3.2.5 Trauma Implants
4.3.3 Dental Implants
4.3.4 Angiography Implants
4.3.4.1 Vascular Closure Devices
4.3.4.2 Angiography Accessories
4.3.4.3 Others
4.4 Global Smart Implants Market by Material
4.4.1 Market Overview
4.4.1.1 Bone Cement
4.4.1.2 Metal
4.4.1.2.1 Cobalt
4.4.1.2.2 Alloy
4.4.1.2.3 Titanium
4.4.1.3 Others
4.5 Global Smart Implants Market by Distribution Channel
4.5.1 Market Overview
4.5.1.1 Hospitals
4.5.1.2 Ambulatory Surgical Centers
4.5.1.3 Clinics
4.5.1.4 Research Laboratories
4.6 Global Smart Implants Market by Region
4.6.1 Market Overview
4.6.1.1 North America
4.6.1.2 Europe
4.6.1.3 Asia Pacific
4.6.1.4 Rest of the World
4.6.2 North America
4.6.2.1 Historical Trend (2016-2022)
4.6.2.2 Forecast Trend (2023-2031)
4.6.2.3 Break Up by Country
4.6.2.3.1 United States of America
4.6.2.3.2 Canada
4.6.3 Europe
4.6.3.1 Historical Trend (2016-2022)
4.6.3.2 Forecast Trend (2023-2031)
4.6.3.3 Break Up by Country
4.6.3.3.1 United Kingdom
4.6.3.3.2 Germany
4.6.3.3.3 France
4.6.3.3.4 Italy
4.6.4 Asia Pacific
4.6.4.1 Historical Trend (2016-2022)
4.6.4.2 Forecast Trend (2023-2031)
4.6.4.3 Break Up by Country
4.6.4.3.1 China
4.6.4.3.2 Japan
4.6.4.3.3 India
4.6.4.3.4 ASEAN
4.6.4.3.5 Australia
4.6.5 Rest of the World
4.6.5.1 Historical Trend (2016-2022)
4.6.5.2 Forecast Trend (2023-2031)
4.6.5.3 Break Up by Country
4.6.5.3.1 Brazil
4.6.5.3.2 Mexico
4.6.5.3.3 Others
5 Trade Data Analysis by HS Code
5.1 Orthopedic Implants- 90213100
5.2 Cardiac Implants- 90189094
5.3 Dental Implants- 90184900
6 Current Scenario Evaluation and Regulatory Framework
6.1 Emerging Therapies and Clinical Trials Synopsis
6.2 Patent Landscape
6.2.1 Patent Overview
6.2.1.1 Patent Status and Expiry
6.2.1.2 Timelines from Device Development to Commercial Launch
6.2.1.3 New Device Application
6.2.1.3.1 Documentation and Approval Process
6.3 Cost of Treatment
6.4 Regulatory Framework
6.4.1 Regulatory Overview
6.4.1.1 US FDA
6.4.1.2 EU EMA
6.4.1.3 INDIA CDSCO
6.4.1.4 JAPAN PMDA
6.4.1.5 Others
7 Global Smart Implants Market Dynamics
7.1 Market Drivers and Constraints
7.2 SWOT Analysis
7.3 Porter’s Five Forces Model
7.4 Key Demand Indicators
7.5 Key Price Indicators
7.6 Industry Events, Initiatives, and Trends
7.7 Value Chain Analysis
8 Supplier Landscape
8.1 Johnson & Johnson Services, Inc.
8.1.1 Company Overview
8.1.2 Product Portfolio
8.1.3 Demographic Reach and Achievements
8.1.4 Mergers and Acquisitions
8.1.5 Certifications
8.2 Medronic plc
8.2.1 Company Overview
8.2.2 Product Portfolio
8.2.3 Demographic Reach and Achievements
8.2.4 Mergers and Acquisitions
8.2.5 Certifications
8.3 Abbott Laboratories
8.3.1 Company Overview
8.3.2 Product Portfolio
8.3.3 Demographic Reach and Achievements
8.3.4 Mergers and Acquisitions
8.3.5 Certifications
8.4 Boston Scientific Corporation
8.4.1 Company Overview
8.4.2 Product Portfolio
8.4.3 Demographic Reach and Achievements
8.4.4 Mergers and Acquisitions
8.4.5 Certifications
8.5 Nevro Corp.
8.5.1 Company Overview
8.5.2 Product Portfolio
8.5.3 Demographic Reach and Achievements
8.5.4 Mergers and Acquisitions
8.5.5 Certifications
8.6 Zimmer Biomet
8.6.1 Company Overview
8.6.2 Product Portfolio
8.6.3 Demographic Reach and Achievements
8.6.4 Mergers and Acquisitions
8.6.5 Certifications
8.7 Cochlear Ltd.
8.7.1 Company Overview
8.7.2 Product Portfolio
8.7.3 Demographic Reach and Achievements
8.7.4 Mergers and Acquisitions
8.7.5 Certifications
8.8 Biotronik
8.8.1 Company Overview
8.8.2 Product Portfolio
8.8.3 Demographic Reach and Achievements
8.8.4 Mergers and Acquisitions
8.8.5 Certifications
8.9 Seneonics, Inc.
8.9.1 Company Overview
8.9.2 Product Portfolio
8.9.3 Demographic Reach and Achievements
8.9.4 Mergers and Acquisitions
8.9.5 Certifications
8.10 Intelligent Implants Ltd.
8.10.1 Company Overview
8.10.2 Product Portfolio
8.10.3 Demographic Reach and Achievements
8.10.4 Mergers and Acquisitions
8.10.5 Certifications
8.11 Freudenberg Group
8.11.1 Company Overview
8.11.2 Product Portfolio
8.11.3 Demographic Reach and Achievements
8.11.4 Mergers and Acquisitions
8.11.5 Certifications
8.12 AstraZeneca
8.12.1 Company Overview
8.12.2 Product Portfolio
8.12.3 Demographic Reach and Achievements
8.12.4 Mergers and Acquisitions
8.12.5 Certifications
8.13 Integra LifeSciences
8.13.1 Company Overview
8.13.2 Product Portfolio
8.13.3 Demographic Reach and Achievements
8.13.4 Mergers and Acquisitions
8.13.5 Certifications
9 Recommendations and Discussion
10 Pricing Models and Strategies (Additional Insight)
10.1 Overview
10.2 Cost Model
10.2.1 Manufacturing Cost Analysis
10.2.2 Procurement Cost Analysis
10.2.3 Clinical Trial Cost Factors
10.3 Pricing Strategies
10.3.1 Competitor Pricing Analysis
10.3.2 Key Assessment of Product Attributes
10.3.3 Pricing Benchmark
11 Global Smart Implants Distribution Model (Additional Insight)
11.1 Overview
11.2 Potential Distributors
11.3 Key Parameters for Distribution Partner Assessment

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings